BioCentury
ARTICLE | Company News

Idec deal

February 6, 1995 8:00 AM UTC

IDEC Pharmaceuticals Corp. (IDPH) IDPH and Seikagaku Corp. will develop a primatized antibody against the CD23 antigen on certain white blood cells to treat allergic rhinitis, asthma and other allerg...